Genzyme revenue up 21% in Q4

REVENUES at biotechnology firm Genzyme, which employs almost 400 people in Co Waterford, rose 21% in the fourth quarter of last year to $1.04 billion (€0.7bn), up from $854m (€577m) in the same period a year earlier.

For the full year just ended, revenue grew 20% to $3.8bn (€2.57bn) from $3.2bn (€2.16bn) in 2006.

Of the products with a Waterford input, Myozyme sales more than doubled in the fourth quarter, rising to $62m (€41.92m) from $30m (€20.28m) in the previous fourth quarter.